Delivery Order SPE2DB22D3019-SPE2DB25FK2YP
Award Date
1/6/25
Potential Completion Date
1/7/25
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,001.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. This is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $37,711.49 firm fixed price contract is for the delivery of dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $37,711.49 and a completion date of July 5, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,777.55, is for the delivery of dapagliflozin 10 mg tablets, a medication used to manage diabetes. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dapagliflozin 10 mg tablets, which are used to treat type 2 diabetes. The contract has a ceiling value of $13,655.93 and a completion date of July 12, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,071.13 firm fixed-price delivery order is for the supply of 4566405164 Dapagliflozin 10 mg tablets, a medication used to manage diabetes. The contract has a ceiling value of $4,071.13 and a completion date of November 13, 2024. This delivery order is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is a $2,116.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,627,303 units of the prescription drug Dapagliflozin 10 mg tablets, which are used to treat type 2 diabetes. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,716.90 contract is for the delivery of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed price and is set to expire on June 12, 2024.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,855.89 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 19, 2024 and was awarded on September 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,187.62 firm fixed-price delivery order is for the supply of dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This award is part of AmerisourceBergen's larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $5,790.60 firm-fixed-price contract is for the supply of 4565046760 - dapagliflozin 10 mg tablets in quantities of 30. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to the...